# 72888-152-05 · Clonazepam Tablet · Rubicon Research Private Limited — FDA drug shortage duration tracker

For 72888-152-05 · Clonazepam Tablet · Rubicon Research Private Limited, package ndc is 72888-152-05; generic name is Clonazepam Tablet; manufacturer is Rubicon Research Private Limited; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 72888-152-05 _(verified: appears in the quote below)_
- **Generic name:** Clonazepam Tablet _(verified: appears in the quote below)_
- **Manufacturer:** Rubicon Research Private Limited _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **FDA note:** Marketed by Advagen Pharma Ltd. _(verified: appears in the quote below)_
- **Initial posting date:** 03/10/2023 _(verified: appears in the quote below)_
- **Last update date:** 06/01/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1271 _(our reading, not quoted from the source)_
- **Dosage form:** Tablet _(verified: appears in its own passage below)_
- **Therapeutic category:** Neurology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "03/10/2023", "package_ndc": "72888-152-05", "generic_name": "Clonazepam Tablet", "contact_info": "sales@advagenpharma.com", "availability": "Available", "related_info": "Marketed by Advagen Pharma Ltd."

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "06/01/2026", "therapeutic_category": [ "Neurology", "Pediatric", "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-05)", "company_name": "Rubicon Research Private Limited", "status": "Current"

### Status

> "update_date": "06/01/2026", "therapeutic_category": [ "Neurology", "Pediatric", "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-05)", "company_name": "Rubicon Research Private Limited", "status": "Current"

### Last update date

> "update_date": "06/01/2026", "therapeutic_category": [ "Neurology", "Pediatric", "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-05)", "company_name": "Rubicon Research Private Limited", "status": "Current"

### Dosage form

> "update_date": "06/01/2026", "therapeutic_category": [ "Neurology", "Pediatric", "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-05)", "company_name": "Rubicon Research Private Limited", "status": "Current"

### Therapeutic category

> "update_date": "06/01/2026", "therapeutic_category": [ "Neurology", "Pediatric", "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-05)", "company_name": "Rubicon Research Private Limited", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).